Literature DB >> 8088270

Spinal electrical stimulation for intractable angina--long-term clinical outcome and safety.

J E Sanderson1, B Ibrahim, D Waterhouse, R B Palmer.   

Abstract

Spinal cord electrical stimulation is an alternative therapy for patients with chronic pain syndromes including angina. Although it has been shown to produce symptomatic relief and reduce ischaemia, doubts remain about its long-term safety. We report here for the first time the results of a follow-up study over a period of 62 months, mean 45 months (range 21-62), of 23 patients who had stimulator units implanted for intractable angina unresponsive to standard therapy. Symptomatic improvement was good and persisted in the majority with a mean (SD) change of NYHA grade from 3.1 (0.8) pre-operatively to 2.0 (0.9) (P < 0.01) immediately after operation and 2.1 (1.07) at the latest follow-up. GTN consumption fell markedly. Mean (SEM) treadmill exercise time increased from 407 (45) s with the stimulator off to 499 (46) s with the stimulator on (P < 0.01). Forty-eight hour ST segment monitoring in those with bipolar leads showed a reduction of total number and duration of ischaemic episodes. There were three deaths, none of which were sudden or unexplained and this mortality rate is acceptable for such a group of patients. Two patients had a myocardial infarction, which was associated with typical pain and not masked by the treatment. Complications related to earlier lead designs were frequent. This study confirms that spinal electrical stimulation is an effective and safe form of alternative therapy for the occasional patient whose angina is unresponsive to standard therapies.

Entities:  

Mesh:

Year:  1994        PMID: 8088270     DOI: 10.1093/oxfordjournals.eurheartj.a060589

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

Review 1.  Neurostimulation treatment for angina pectoris.

Authors:  S Murray; P D Collins; M A James
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 2.  Spinal cord stimulation: an update.

Authors:  Steven Falowski; Amanda Celii; Ashwini Sharan
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 3.  The role of the autonomic nervous system in sudden cardiac death.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Prog Cardiovasc Dis       Date:  2008 May-Jun       Impact factor: 8.194

4.  Long-term outcome of spinal cord electrical stimulation in patients with refractory chest pain.

Authors:  J P Bagger; B S Jensen; G Johannsen
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

5.  Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. The Working Group on Neurocardiology.

Authors:  I A TenVaarwerk; G A Jessurun; M J DeJongste; C Andersen; C Mannheimer; T Eliasson; W Tadema; M J Staal
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

6.  Spinal cord stimulation significantly decreases the need for acute hospital admission for chest pain in patients with refractory angina pectoris.

Authors:  S Murray; K G Carson; P D Ewings; P D Collins; M A James
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

Review 7.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

8.  Spinal Cord Stimulation for the Treatment of Angina Pectoris.

Authors:  Wilbert S. Aronow; William H. Frishman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-02

9.  The effect of transcutaneous electrical nerve stimulation (TENS) on autonomic cardiovascular reflexes.

Authors:  J E Sanderson; B Tomlinson; M S Lau; K W So; A H Cheung; J A Critchley; K S Woo
Journal:  Clin Auton Res       Date:  1995-04       Impact factor: 4.435

10.  Syndrome X.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.